B of A Securities analyst Sherif El-Sabbahy reinstates Charah Solns (NYSE:CHRA) with a Underperform.
Precigen Touts Encouraging Data From Autologous UltraCAR-T Cells Manufactured Overnight For Next Day Infusion In Ovarian Cancer
Precigen Inc (NASDAQ:PGEN) presented data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from the Phase…